{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:57:21Z","timestamp":1791176241277,"version":"4.1.0"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["DEC-2012\/05\/D\/NZ2\/02238"],"award-info":[{"award-number":["DEC-2012\/05\/D\/NZ2\/02238"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Polish Ministry of Science and Higher Education","award":["IP2012 014972"],"award-info":[{"award-number":["IP2012 014972"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.meegid.2013.10.021","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T13:01:15Z","timestamp":1383570075000},"page":"67-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Phylogeny and molecular evolution of the hepatitis C virus"],"prefix":"10.1016","volume":"21","author":[{"given":"Paulina","family":"Jackowiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Kuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Budzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2013.10.021_b0005","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ajg.2013.205","article-title":"A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing","volume":"108","author":"Abe","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"Pt 10","key":"10.1016\/j.meegid.2013.10.021_b0010","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1099\/0022-1317-73-10-2725","article-title":"Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan","volume":"73","author":"Abe","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0015","doi-asserted-by":"crossref","first-page":"e1000745","DOI":"10.1371\/journal.pcbi.1000745","article-title":"A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants","volume":"6","author":"Adiwijaya","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0020","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0168-8278(07)61604-3","article-title":"Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon\/ribavirin (pegIFN\/RBV) retreatment in patients with HCV-1 infection and prior non-response to pegIFN\/RBV: one-year results","volume":"46","author":"Afdhal","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jmv.23579","article-title":"Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1","volume":"85","author":"Akuta","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.18388\/abp.2005_3395","article-title":"Two types of non-homologous RNA recombination in brome mosaic virus","volume":"52","author":"Alejska","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.meegid.2013.10.021_b0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tim.2010.09.005","article-title":"Epidemiological and clinical consequences of within-host evolution","volume":"19","author":"Alizon","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0040","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/JVI.74.6.2541-2549.2000","article-title":"Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters","volume":"74","author":"Allain","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0045","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"Allen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0168-8278(98)80340-1","article-title":"Correlation between virus genotype and chronicity rate in acute hepatitis C","volume":"28","author":"Amoroso","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0055","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1086\/386338","article-title":"Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation","volume":"189","author":"Arenas","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0060","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1099\/vir.0.020818-0","article-title":"How RNA viruses maintain their genome integrity","volume":"91","author":"Barr","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0070","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2893.2006.00722.x","article-title":"Absence of HCV viral recombination following superinfection","volume":"13","author":"Bernardin","year":"2006","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2334-10-36","article-title":"Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response","volume":"10","author":"Bittar","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0090","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1073\/pnas.1103764108","article-title":"Role of donor genital tract HIV-1 diversity in the transmission bottleneck","volume":"108","author":"Boeras","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0095","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JCM.01982-06","article-title":"Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay","volume":"45","author":"Bouchardeau","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0100","doi-asserted-by":"crossref","first-page":"e1002243","DOI":"10.1371\/journal.ppat.1002243","article-title":"Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection","volume":"7","author":"Bull","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2013.10.021_b0105","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0801774105","article-title":"Coordinated evolution of the hepatitis C virus","volume":"105","author":"Campo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2893.2009.01109.x","article-title":"Evidence for action of ribavirin through the hepatitis C virus RNA polymerase","volume":"16","author":"Cannon","year":"2009","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0115","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JCM.42.9.4365-4369.2004","article-title":"Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1","volume":"42","author":"Canobio","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.2002.009936","article-title":"Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis","volume":"53","author":"Castera","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.meegid.2013.10.021_b0125","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/JVI.79.5.3071-3083.2005","article-title":"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection","volume":"79","author":"Chambers","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0130","doi-asserted-by":"crossref","first-page":"e8209","DOI":"10.1371\/journal.pone.0008209","article-title":"Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice","volume":"4","author":"Chevaliez","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bpg.2012.09.006","article-title":"Virology of hepatitis C virus infection","volume":"26","author":"Chevaliez","year":"2012","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.meegid.2013.10.021_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2012.18.2.219","article-title":"Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience","volume":"18","author":"Cho","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.10.021_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2010.03.017","article-title":"A multicenter evaluation of the Abbott RealTime HCV Genotype II assay","volume":"167","author":"Ciotti","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2013.10.021_b0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2008.11.049","article-title":"Rare birds in North America: acute hepatitis C cohorts","volume":"136","author":"Cox","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0165","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.00201-09","article-title":"Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo","volume":"83","author":"Cuevas","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0170","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/JVI.02778-12","article-title":"Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients","volume":"87","author":"Dietz","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virusres.2007.02.001","article-title":"Quasispecies and its impact on viral hepatitis","volume":"127","author":"Domingo","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.meegid.2013.10.021_b0180","series-title":"Quasispecies: Concepts and Implications for Virology","first-page":"51","article-title":"Viruses as quasispecies: biological implications","author":"Domingo","year":"2006"},{"key":"10.1016\/j.meegid.2013.10.021_b0185","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(78)90223-4","article-title":"Nucleotide sequence heterogeneity of an RNA phage population","volume":"13","author":"Domingo","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2013.10.021_b0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.meegid.2013.10.021_b0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1751-2980.2012.00636.x","article-title":"Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients\u2019 characteristics and clinical parameters","volume":"13","author":"Dong","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0200","doi-asserted-by":"crossref","first-page":"e1003438","DOI":"10.1371\/journal.ppat.1003438","article-title":"Evidence for novel hepaciviruses in rodents","volume":"9","author":"Drexler","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2013.10.021_b0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-308X(03)54008-8","article-title":"Inference of viral evolutionary rates from molecular sequences","volume":"54","author":"Drummond","year":"2003","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.meegid.2013.10.021_b0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-2148-7-214","article-title":"BEAST: Bayesian evolutionary analysis by sampling trees","volume":"7","author":"Drummond","year":"2007","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.20087","article-title":"Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes","volume":"39","author":"Ducoulombier","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrg2323","article-title":"Rates of evolutionary change in viruses: patterns and determinants","volume":"9","author":"Duffy","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.meegid.2013.10.021_b0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"55","author":"EASL","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0230","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.23290","article-title":"High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy","volume":"50","author":"Fan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0031-1297925","article-title":"New insights into the HCV quasispecies and compartmentalization","volume":"31","author":"Farci","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0240","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1073\/pnas.0602546103","article-title":"Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively","volume":"103","author":"Farci","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.10.021_b0250","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.052712599","article-title":"Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome","volume":"99","author":"Farci","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0255","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2013.10.021_b0260","series-title":"Chronic Hepatitis C in Children \u2013 Clinical and Virological Factors Affecting Interferon Alpha or Interferon Alpha and Ribavirin Therapy","author":"Figlerowicz","year":"2005"},{"key":"10.1016\/j.meegid.2013.10.021_b0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/med.10045","article-title":"Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections","volume":"23","author":"Figlerowicz","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.meegid.2013.10.021_b0270","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00705-010-0789-7","article-title":"Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy","volume":"155","author":"Figlerowicz","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0275","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.meegid.2009.07.011","article-title":"The quasispecies nature and biological implications of the hepatitis C virus","volume":"9","author":"Fishman","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2013.10.021_b0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cgh.2012.10.006","article-title":"Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection","volume":"11","author":"Flamm","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0285","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22835","article-title":"The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients","volume":"49","author":"Flisiak","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/17130","article-title":"Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes","volume":"397","author":"Gao","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2013.10.021_b0300","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.510280633","article-title":"Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients","volume":"28","author":"Garcia-Monzon","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s15010-006-5037-4","article-title":"Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C","volume":"34","author":"Gerotto","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.meegid.2013.10.021_b0310","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2893.2009.01071.x","article-title":"Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers","volume":"16","author":"Gismondi","year":"2009","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0320","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1128\/JVI.05053-11","article-title":"Characterization of glycosylation profiles of HIV-1 transmitted\/founder envelopes by mass spectrometry","volume":"85","author":"Go","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0325","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/v3102006","article-title":"Recombination in hepatitis C virus","volume":"3","author":"Gonzalez-Candelas","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2013.10.021_b0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcv.2013.05.005","article-title":"Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice","volume":"58","author":"Gonzalez","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2148-11-131","article-title":"The mode and tempo of hepatitis C virus evolution within and among hosts","volume":"11","author":"Gray","year":"2011","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0340","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.coviro.2012.08.001","article-title":"Virus population bottlenecks during within-host progression and host-to-host transmission","volume":"2","author":"Gutierrez","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.meegid.2013.10.021_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350501000118","article-title":"Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes","volume":"10","author":"Hnatyszyn","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2013.10.021_b0350","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/j.gastro.2006.12.005","article-title":"Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy","volume":"132","author":"Hofmann","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0355","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.meegid.2010.03.006","article-title":"Does hepatitis C virus really form quasispecies?","volume":"10","author":"Holmes","year":"2010","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2013.10.021_b0360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JVI.76.1.460-462.2002","article-title":"Is the quasispecies concept relevant to RNA viruses?","volume":"76","author":"Holmes","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0365","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JCM.02034-12","article-title":"Evaluation of two hepatitis C virus genotyping assays based on the 5\u2032 untranslated region (UTR): the limitations of 5\u2032 UTR-based assays and the need for a supplementary sequencing-based approach","volume":"50","author":"Hong","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0370","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2174\/138920111798377030","article-title":"Mechanisms involved in the development of chronic hepatitis C as potential targets of antiviral therapy","volume":"12","author":"Jackowiak","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.meegid.2013.10.021_b0375","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.virusres.2012.05.005","article-title":"Evolution of hepatitis C virus hypervariable region 1 in chronically infected children","volume":"167","author":"Jackowiak","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.meegid.2013.10.021_b0380","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0385","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-13-61","article-title":"Analysis of HCV quasispecies dynamic under selective pressure of combined therapy","volume":"13","author":"Jardim","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0395","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.10.021_b0400","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3350\/cmh.2013.19.1.26","article-title":"Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?","volume":"19","author":"Jung","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0405","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jmv.20714","article-title":"A natural inter-genotypic (2b\/1b) recombinant of hepatitis C virus in the Philippines","volume":"78","author":"Kageyama","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0410","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1099\/vir.0.79984-0","article-title":"Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation","volume":"85","author":"Kalinina","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0415","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JVI.76.8.4034-4043.2002","article-title":"A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg","volume":"76","author":"Kalinina","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0420","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.22127","article-title":"Hepatitis C genotype 4: what we know and what we don\u2019t yet know","volume":"47","author":"Kamal","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3350\/kjhep.2008.14.3.318","article-title":"Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection","volume":"14","author":"Kang","year":"2008","journal-title":"Korean J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0430","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1101794108","article-title":"Characterization of a canine homolog of hepatitis C virus","volume":"108","author":"Kapoor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0435","doi-asserted-by":"crossref","first-page":"e00216","DOI":"10.1128\/mBio.00216-13","article-title":"Identification of rodent homologs of hepatitis C virus and pegiviruses","volume":"4","author":"Kapoor","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.meegid.2013.10.021_b0440","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1099\/vir.0.80479-0","article-title":"Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture","volume":"86","author":"Kato","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0445","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2165\/00003495-200868090-00006","article-title":"Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection","volume":"68","author":"Keam","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.meegid.2013.10.021_b0450","doi-asserted-by":"crossref","first-page":"e34372","DOI":"10.1371\/journal.pone.0034372","article-title":"Hepatitis C viral evolution in genotype 1 treatment-naive and treatment-experienced patients receiving telaprevir-based therapy in clinical trials","volume":"7","author":"Kieffer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0455","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/jmv.23706","article-title":"Prevalence of hepatitis C virus genotypes in risk groups in the Republic of Macedonia: a 5years survey","volume":"85","author":"Kiprijanovska","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-394-3_4","article-title":"Nomenclature and numbering of the hepatitis C virus","volume":"510","author":"Kuiken","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0465","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1128\/JVI.00995-07","article-title":"Viral sequence evolution in acute hepatitis C virus infection","volume":"81","author":"Kuntzen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2013.10.021_b0475","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2012.10.019","article-title":"Perspectives and challenges of interferon-free therapy for chronic hepatitis C","volume":"58","author":"Lange","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0480","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/ISB-2012-0456","article-title":"Coordinated evolution among hepatitis C virus genomic sites is coupled to host factors and resistance to interferon","volume":"11","author":"Lara","year":"2012","journal-title":"In Silico Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0485","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.06.005","article-title":"Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion","volume":"127","author":"Laskus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0490","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1128\/JVI.00888-13","article-title":"A novel hepacivirus with an unusually long and intrinsically disordered NS5A protein in a wild Old World primate","volume":"87","author":"Lauck","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0495","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/JVI.02639-06","article-title":"New natural intergenotypic (2\/5) recombinant of hepatitis C virus","volume":"81","author":"Legrand-Abravanel","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0500","doi-asserted-by":"crossref","first-page":"e1000520","DOI":"10.1371\/journal.pcbi.1000520","article-title":"Bayesian phylogeography finds its roots","volume":"5","author":"Lemey","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0505","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0168-8278(98)80247-X","article-title":"Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection","volume":"29","author":"Leone","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0510","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0515","doi-asserted-by":"crossref","first-page":"e19562","DOI":"10.1371\/journal.pone.0019562","article-title":"Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0520","doi-asserted-by":"crossref","first-page":"e1002880","DOI":"10.1371\/journal.ppat.1002880","article-title":"Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing","volume":"8","author":"Li","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2013.10.021_b0525","series-title":"Fields Virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.meegid.2013.10.021_b0530","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/hep.25575","article-title":"Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution","volume":"55","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0535","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/JVI.75.3.1437-1449.2001","article-title":"Mutations in hepatitis C virus RNAs conferring cell culture adaptation","volume":"75","author":"Lohmann","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0540","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep.510290306","article-title":"Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]","volume":"29","author":"Lopez-Labrador","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0545","doi-asserted-by":"crossref","first-page":"e1000565","DOI":"10.1371\/journal.pcbi.1000565","article-title":"The evolutionary dynamics of a rapidly mutating virus within and between hosts: the case of hepatitis C virus","volume":"5","author":"Luciani","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.meegid.2013.10.021_b0550","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.gastro.2007.03.035","article-title":"Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy","volume":"132","author":"Lutchman","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0555","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3201\/eid1812.120498","article-title":"Nonprimate hepaciviruses in domestic horses, United kingdom","volume":"18","author":"Lyons","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0560","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1073\/pnas.1012464108","article-title":"Masking the 5\u2032 terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex","volume":"108","author":"Machlin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 7","key":"10.1016\/j.meegid.2013.10.021_b0565","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1099\/0022-1317-78-7-1521","article-title":"Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma","volume":"78","author":"Maggi","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0570","doi-asserted-by":"crossref","first-page":"e1000198","DOI":"10.1371\/journal.pmed.1000198","article-title":"The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis","volume":"6","author":"Magiorkinis","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IPC.0b013e3182425b13","article-title":"Clinical picture and liver histology of chronic hepatitis C in children","volume":"20","author":"Mania","year":"2012","journal-title":"Infect. Dis. Clin. Pract."},{"key":"10.1016\/j.meegid.2013.10.021_b0580","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1099\/vir.0.011569-0","article-title":"Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa","volume":"90","author":"Markov","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0585","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"McHutchison","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0590","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0595","series-title":"Deep sequencing analysis of the association between the quasispecies nature of the hepatitis c virus core region and disease progression","author":"Miura","year":"2013"},{"key":"10.1016\/j.meegid.2013.10.021_b0600","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1743-422X-5-78","article-title":"Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a","volume":"5","author":"Moreau","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2013.10.021_b0610","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2893.2010.01367.x","article-title":"Genetic recombination of the hepatitis C virus: clinical implications","volume":"18","author":"Morel","year":"2011","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0615","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1073\/pnas.97.13.6967","article-title":"The evolution of RNA viruses: a population genetics view","volume":"97","author":"Moya","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0620","doi-asserted-by":"crossref","first-page":"e24907","DOI":"10.1371\/journal.pone.0024907","article-title":"Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing","volume":"6","author":"Nasu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0625","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0630","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.10.021_b0635","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JCM.05715-11","article-title":"Use of illumina deep sequencing technology to differentiate hepatitis C virus variants","volume":"50","author":"Ninomiya","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0640","doi-asserted-by":"crossref","first-page":"e42002","DOI":"10.1371\/journal.pone.0042002","article-title":"Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa","volume":"7","author":"Njouom","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0645","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.00312-06","article-title":"Identification of a naturally occurring recombinant genotype 2\/6 hepatitis C virus","volume":"80","author":"Noppornpanth","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0650","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/JCM.01122-06","article-title":"Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5\u2032 untranslated regions","volume":"44","author":"Noppornpanth","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0655","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","article-title":"Nucleotide sequence and mutation rate of the H strain of hepatitis C virus","volume":"88","author":"Ogata","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0660","series-title":"Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients; ultra-deep sequencing analysis","author":"Ohtsuru","year":"2013"},{"key":"10.1016\/j.meegid.2013.10.021_b0665","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.510290117","article-title":"Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver","volume":"29","author":"Okuda","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0670","doi-asserted-by":"crossref","first-page":"e6579","DOI":"10.1371\/journal.pone.0006579","article-title":"The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy","volume":"4","author":"Pang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0675","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4166\/kjg.2012.60.5.306","article-title":"Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis","volume":"60","author":"Park","year":"2012","journal-title":"Korean J. Gastroenterol."},{"key":"10.1016\/j.meegid.2013.10.021_b0680","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1089-3261(02)00065-X","article-title":"Hepatitis C virus genetic variability: pathogenic and clinical implications","volume":"7","author":"Pawlotsky","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0685","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.24262","article-title":"Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus","volume":"53","author":"Pawlotsky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0690","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/JVI.72.4.2795-2805.1998","article-title":"Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations","volume":"72","author":"Pawlotsky","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0695","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.0.CO;2-3","article-title":"Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C","volume":"54","author":"Pawlotsky","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0700","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2005.07.003","article-title":"Mutagenic effects of ribavirin in vivo","volume":"43","author":"Perelson","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0705","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2165\/11208370-000000000-00000","article-title":"Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C","volume":"72","author":"Perry","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.meegid.2013.10.021_b0710","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000348506","article-title":"Age and gender distribution of hepatitis C virus genotypes in the metropolitan area of Naples","volume":"56","author":"Petruzziello","year":"2013","journal-title":"Intervirology"},{"key":"10.1016\/j.meegid.2013.10.021_b0715","doi-asserted-by":"crossref","first-page":"e16797","DOI":"10.1371\/journal.pone.0016797","article-title":"Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity","volume":"6","author":"Pfafferott","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0720","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2013.06.002","article-title":"Nucleotide polymorphisms in the 5\u2032-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype","volume":"193","author":"Pollicita","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2013.10.021_b0725","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0730","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1073\/pnas.1105797108","article-title":"Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance","volume":"108","author":"Powdrill","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0735","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression\u2013a systematic review and meta-analysis","volume":"18","author":"Probst","year":"2011","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0740","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1099\/vir.0.80526-0","article-title":"Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C","volume":"86","author":"Puig-Basagoiti","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0745","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.01501-08","article-title":"Genetic history of hepatitis C virus in East Asia","volume":"83","author":"Pybus","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0750","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1126\/science.1058321","article-title":"The epidemic behavior of the hepatitis C virus","volume":"292","author":"Pybus","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.meegid.2013.10.021_b0755","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrg2583","article-title":"Evolutionary analysis of the dynamics of viral infectious disease","volume":"10","author":"Pybus","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.meegid.2013.10.021_b0760","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1073\/pnas.1303037110","article-title":"Bats are a major natural reservoir for hepaciviruses and pegiviruses","volume":"110","author":"Quan","year":"2013","journal-title":"Proc.Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0765","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcv.2008.06.019","article-title":"HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1","volume":"43","author":"Quesnel-Vallieres","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0770","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1128\/JVI.79.21.13594-13605.2005","article-title":"Quantitative analysis of the hepatitis C virus replication complex","volume":"79","author":"Quinkert","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0775","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jhep.2009.01.019","article-title":"Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis","volume":"50","author":"Raimondi","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0780","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1128\/JVI.02204-10","article-title":"Temporal variations in the hepatitis C virus intrahost population during chronic infection","volume":"85","author":"Ramachandran","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0785","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1128\/JVI.78.22.12207-12217.2004","article-title":"De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities","volume":"78","author":"Ranjith-Kumar","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0790","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-005-0064-3","article-title":"Children with hepatitis C","volume":"7","author":"Rao","year":"2005","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.meegid.2013.10.021_b0795","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/315786","article-title":"Genetic epidemiology of hepatitis C virus throughout Egypt","volume":"182","author":"Ray","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2013.10.021_b0800","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1743-422X-8-346","article-title":"Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence","volume":"8","author":"Revie","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2013.10.021_b0805","doi-asserted-by":"crossref","first-page":"e1002881","DOI":"10.1371\/journal.ppat.1002881","article-title":"Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate","volume":"8","author":"Ribeiro","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2013.10.021_b0810","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2893.2001.00295.x","article-title":"Viral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related viruses","volume":"8","author":"Robertson","year":"2001","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0815","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hep.20581","article-title":"Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C","volume":"41","author":"Rothman","year":"2005","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2013.10.021_b0820","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0168-8278(99)80388-2","article-title":"Hepatitis C virus infection in children","volume":"31","author":"Ruiz-Moreno","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2013.10.021_b0825","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1128\/JVI.00378-13","article-title":"Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction","volume":"87","author":"Sagan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0830","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00239-001-0018-9","article-title":"Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences","volume":"54","author":"Salemi","year":"2002","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.meegid.2013.10.021_b0835","doi-asserted-by":"crossref","first-page":"e14132","DOI":"10.1371\/journal.pone.0014132","article-title":"Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors","volume":"5","author":"Saludes","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0840","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.74.2.661-668.2000","article-title":"Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy","volume":"74","author":"Sandres","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0845","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0850","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1053\/j.gastro.2007.02.037","article-title":"Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir","volume":"132","author":"Sarrazin","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0855","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1128\/JVI.02144-06","article-title":"Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes","volume":"81","author":"Schaller","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0860","doi-asserted-by":"crossref","first-page":"e1003228","DOI":"10.1371\/journal.ppat.1003228","article-title":"Productive homologous and non-homologous recombination of hepatitis C virus in cell culture","volume":"9","author":"Scheel","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2013.10.021_b0865","doi-asserted-by":"crossref","first-page":"e3239","DOI":"10.1371\/journal.pone.0003239","article-title":"Evidence of recombination in intrapatient populations of hepatitis C virus","volume":"3","author":"Sentandreu","year":"2008","journal-title":"PLoS ONE"},{"issue":"Iii\u2013iv","key":"10.1016\/j.meegid.2013.10.021_b0870","first-page":"1","article-title":"Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation","volume":"8","author":"Shepherd","year":"2004","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.meegid.2013.10.021_b0875","doi-asserted-by":"crossref","first-page":"e41997","DOI":"10.1371\/journal.pone.0041997","article-title":"Recombination in hepatitis C virus: identification of four novel naturally occurring inter-subtype recombinants","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b0880","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2013.10.021_b0885","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/JCM.01249-12","article-title":"Performance of the Abbott RealTime HCV Genotype II RUO assay","volume":"50","author":"Shinol","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0890","first-page":"93","article-title":"Hepatitis C in childhood","volume":"100","author":"Sibal","year":"2002","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.meegid.2013.10.021_b0895","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gut.40.3.291","article-title":"Clinical relevance of hepatitis C virus genotypes","volume":"40","author":"Simmonds","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.meegid.2013.10.021_b0900","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-82-4-693","article-title":"The origin and evolution of hepatitis viruses in humans","volume":"82","author":"Simmonds","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0905","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus\u201315years on","volume":"85","author":"Simmonds","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0910","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"Simmonds","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2013.10.021_b1050","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes, updated criteria and assignment web resource","author":"Smith","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2013.10.021_b0920","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/CCLM.2010.093","article-title":"Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping","volume":"48","author":"Sohn","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.meegid.2013.10.021_b0925","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0930","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2011.08.015","article-title":"Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir","volume":"52","author":"Susser","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0935","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"Tamura","year":"2011","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2013.10.021_b0940","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1099\/vir.0.82855-0","article-title":"Contribution of insertions and deletions to the variability of hepatitis C virus populations","volume":"88","author":"Torres-Puente","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0945","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1128\/JVI.01748-06","article-title":"Superinfection exclusion in cells infected with hepatitis C virus","volume":"81","author":"Tscherne","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0950","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hepres.2004.02.014","article-title":"Changes of HCV quasispecies during combination therapy with interferon and ribavirin","volume":"29","author":"Ueda","year":"2004","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.meegid.2013.10.021_b0955","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1128\/JVI.79.9.5732-5742.2005","article-title":"Homologous crossovers among molecules of brome mosaic bromovirus RNA1 or RNA2 segments in vivo","volume":"79","author":"Urbanowicz","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0960","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.patbio.2009.07.023","article-title":"Hepatitis C virus genotyping: comparison of the Abbott RealTime HCV Genotype II assay and NS5B sequencing","volume":"58","author":"Vaghefi","year":"2010","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.meegid.2013.10.021_b0965","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2893.2006.00773.x","article-title":"Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?","volume":"14","author":"Vallet","year":"2007","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.meegid.2013.10.021_b0970","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2013.10.021_b0975","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/jlts.2002.36393","article-title":"Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation","volume":"8","author":"Vargas","year":"2002","journal-title":"Liver Transpl."},{"key":"10.1016\/j.meegid.2013.10.021_b0980","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/JVI.80.9.4220-4226.2006","article-title":"Investigating the origin and spread of hepatitis C virus genotype 5a","volume":"80","author":"Verbeeck","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0985","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2013.10.021_b0990","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1128\/JVI.01217-10","article-title":"Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing","volume":"84","author":"Verbinnen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b0995","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1469-0691.2010.03430.x","article-title":"New HCV therapies on the horizon","volume":"17","author":"Vermehren","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2013.10.021_b1000","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s150100050005","article-title":"Mixed infection with two types of hepatitis C virus is probably a rare event","volume":"28","author":"Viazov","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.meegid.2013.10.021_b1005","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1128\/JVI.02271-09","article-title":"Hepatitis C virus transmission bottlenecks analyzed by deep sequencing","volume":"84","author":"Wang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b1010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/JVI.01047-12","article-title":"Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis","volume":"87","author":"Webster","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b1015","unstructured":"WHO, 2012. Hepatitis C. Fact sheet N\u00b0164 July 2012."},{"key":"10.1016\/j.meegid.2013.10.021_b1020","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1128\/JVI.00896-08","article-title":"Comparative analysis of nearly full-length hepatitis C virus quasispecies from patients experiencing viral breakthrough during antiviral therapy: clustered mutations in three functional genes, E2, NS2, and NS5a","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2013.10.021_b1025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5812\/hepatmon.5123","article-title":"Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china","volume":"12","author":"Yan","year":"2012","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.meegid.2013.10.021_b1030","doi-asserted-by":"crossref","first-page":"e64698","DOI":"10.1371\/journal.pone.0064698","article-title":"The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions","volume":"8","author":"Yuan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.meegid.2013.10.021_b1035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2013.10.021_b1040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1024\/0369-8394.94.18.721","article-title":"Treatment of hepatitis C virus infection","volume":"94","author":"Zeuzem","year":"2005","journal-title":"Praxis (Bern 1994)"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134813003936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134813003936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T15:31:12Z","timestamp":1746027072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134813003936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":208,"alternative-id":["S1567134813003936"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2013.10.021","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phylogeny and molecular evolution of the hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2013.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}